Article Details

AstraZeneca's Fasenra Flunks Late-Stage Trial In Patients With Esophagus Inflammation

Retrieved on: 2022-10-25 17:17:46

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Fasenra Flunks Late-Stage Trial In Patients With Esophagus Inflammation. View article details on HISWAI: https://www.benzinga.com/general/biotech/22/10/29390917/astrazenecas-fasenra-flunks-late-stage-trial-in-patients-with-esophagus-inflammation

Excerpt

AstraZeneca Plc. AZN+1.14%+ Free Alerts. has reported topline data from the MESSINA Phase 3 trial Fasenra (benralizumab) in Eosinophilic ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up